Next Article in Journal
Quaternized Chitosan-Capped Mesoporous Silica Nanoparticles as Nanocarriers for Controlled Pesticide Release
Next Article in Special Issue
Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer
Previous Article in Journal
Stress Waves and Characteristics of Zigzag and Armchair Silicene Nanoribbons
Previous Article in Special Issue
Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization
Article Menu

Export Article

Open AccessReview
Nanomaterials 2016, 6(7), 125; doi:10.3390/nano6070125

Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery

1
National Research Council, Institute for Chemical and Physical Processes, Messina 98158, Italy
2
National Research Council, Institute of Nanostructured Materials, Roma 00015, Italy
3
Department of Chemical Sciences, biological, pharmaceutical and environmental, University of Messina, Messina 98166, Italy
4
Department of Physics and Earth Sciences, University of Messina, Messina 98166, Italy
5
Frank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Dubna, Moscow 141980, Russia
*
Author to whom correspondence should be addressed.
Academic Editor: Luigi Pasqua
Received: 6 April 2016 / Revised: 14 June 2016 / Accepted: 17 June 2016 / Published: 25 June 2016
(This article belongs to the Special Issue Nanomaterials for Cancer Therapies)
View Full-Text   |   Download PDF [5811 KB, uploaded 25 June 2016]   |  

Abstract

The development of smart nanocarriers for the delivery of therapeutic drugs has experienced considerable expansion in recent decades, with the development of new medicines devoted to cancer treatment. In this respect a wide range of strategies can be developed by employing liposome nanocarriers with desired physico-chemical properties that, by exploiting a combination of a number of suitable soft interactions, can facilitate the transit through the biological barriers from the point of administration up to the site of drug action. As a result, the materials engineer has generated through the bottom up approach a variety of supramolecular nanocarriers for the encapsulation and controlled delivery of therapeutics which have revealed beneficial developments for stabilizing drug compounds, overcoming impediments to cellular and tissue uptake, and improving biodistribution of therapeutic compounds to target sites. Herein we present recent advances in liposome drug delivery by analyzing the main structural features of liposome nanocarriers which strongly influence their interaction in solution. More specifically, we will focus on the analysis of the relevant soft interactions involved in drug delivery processes which are responsible of main behaviour of soft nanocarriers in complex physiological fluids. Investigation of the interaction between liposomes at the molecular level can be considered an important platform for the modeling of the molecular recognition processes occurring between cells. Some relevant strategies to overcome the biological barriers during the drug delivery of the nanocarriers are presented which outline the main structure-properties relationships as well as their advantages (and drawbacks) in therapeutic and biomedical applications. View Full-Text
Keywords: liposomes; drug delivery; phospholipids vesicles systems; nanotechnology liposomes; drug delivery; phospholipids vesicles systems; nanotechnology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Lombardo, D.; Calandra, P.; Barreca, D.; Magazù, S.; Kiselev, M.A. Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery. Nanomaterials 2016, 6, 125.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nanomaterials EISSN 2079-4991 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top